RU2213564C2 - Фармацевтические составы для перорального введения молекулярного йода - Google Patents

Фармацевтические составы для перорального введения молекулярного йода Download PDF

Info

Publication number
RU2213564C2
RU2213564C2 RU2000107852/14A RU2000107852A RU2213564C2 RU 2213564 C2 RU2213564 C2 RU 2213564C2 RU 2000107852/14 A RU2000107852/14 A RU 2000107852/14A RU 2000107852 A RU2000107852 A RU 2000107852A RU 2213564 C2 RU2213564 C2 RU 2213564C2
Authority
RU
Russia
Prior art keywords
iodine
iodide
iodate
sodium
molecular iodine
Prior art date
Application number
RU2000107852/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2000107852A (ru
Inventor
Йонгджун ДУАН
Джон ХИКИ
Рик ПАНИКУЧЧИ
Джек КЕССЛЕР
Original Assignee
Симболлон Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Симболлон Корпорейшн filed Critical Симболлон Корпорейшн
Publication of RU2000107852A publication Critical patent/RU2000107852A/ru
Application granted granted Critical
Publication of RU2213564C2 publication Critical patent/RU2213564C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
RU2000107852/14A 1997-10-29 1998-10-27 Фармацевтические составы для перорального введения молекулярного йода RU2213564C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US960149 1997-10-29
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine

Publications (2)

Publication Number Publication Date
RU2000107852A RU2000107852A (ru) 2002-01-10
RU2213564C2 true RU2213564C2 (ru) 2003-10-10

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000107852/14A RU2213564C2 (ru) 1997-10-29 1998-10-27 Фармацевтические составы для перорального введения молекулярного йода

Country Status (17)

Country Link
US (1) US5885592A (cg-RX-API-DMAC7.html)
EP (1) EP1024815B1 (cg-RX-API-DMAC7.html)
JP (1) JP4187410B2 (cg-RX-API-DMAC7.html)
KR (1) KR100412219B1 (cg-RX-API-DMAC7.html)
CN (1) CN1150904C (cg-RX-API-DMAC7.html)
AT (1) ATE231725T1 (cg-RX-API-DMAC7.html)
AU (1) AU750627B2 (cg-RX-API-DMAC7.html)
BR (1) BR9812588A (cg-RX-API-DMAC7.html)
CA (1) CA2301503C (cg-RX-API-DMAC7.html)
DE (1) DE69811105T2 (cg-RX-API-DMAC7.html)
DK (1) DK1024815T3 (cg-RX-API-DMAC7.html)
ES (1) ES2191973T3 (cg-RX-API-DMAC7.html)
IL (1) IL134778A0 (cg-RX-API-DMAC7.html)
NO (1) NO20001673L (cg-RX-API-DMAC7.html)
PT (1) PT1024815E (cg-RX-API-DMAC7.html)
RU (1) RU2213564C2 (cg-RX-API-DMAC7.html)
WO (1) WO1999021567A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
CA2317587A1 (en) * 1998-01-06 1999-07-15 Fujisawa Pharmaceutical Co., Ltd. Solid iodophor preparations and process for producing the same
JP2002518351A (ja) * 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
PT1195178E (pt) * 2000-10-06 2006-10-31 Dmg Italia Srl Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar.
RU2201229C1 (ru) * 2002-03-26 2003-03-27 Миронов Владимир Андреевич Способ оздоровления организма
ATE497351T1 (de) * 2003-06-20 2011-02-15 Hills Pet Nutrition Inc Verfahren für die schilddrüsenüberfunktion bei der katze sowie zusammensetzungen mit eingeschränktem jodgehalt
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
JP5356831B2 (ja) * 2006-01-26 2013-12-04 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ネコ科動物の甲状腺機能亢進症を治療するための方法及び組成物
CN101489411A (zh) * 2006-05-12 2009-07-22 希尔氏宠物营养品公司 用于预防或治疗具有甲状腺机能亢进的猫科动物的慢性肾衰竭的组合物和方法
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CA2656608C (en) * 2006-07-03 2014-09-16 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
US20140072598A1 (en) * 2011-05-16 2014-03-13 Shokan Sabirkhanovich Begaliev Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技(潍坊)有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
WO2015120458A1 (en) * 2014-02-10 2015-08-13 Fred Hutchinson Cancer Research Center Halogen treatment of heart attack and ischemic injury
SG11201607686VA (en) 2014-03-31 2016-10-28 Iotech International Inc Stable compositions of uncomplexed iodine and methods of use
WO2017185060A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
CA3031447A1 (en) 2016-07-21 2018-01-25 Iogen, Llc Emollient topical disinfectants
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
WO2021198938A1 (ja) * 2020-03-31 2021-10-07 タイ ミン ファーマシューティカルズ ジェイエスシー 癌または子宮内膜症の患者における癌、子宮内膜症および疼痛の治療のためのジイソプロピルアミン化合物およびヨウ素
BR112023001995A2 (pt) 2020-08-13 2023-02-28 I2Pure Corp Composições de alta concentração de iodo molecular, formulações farmacêuticas, preparação e usos
US20240350534A1 (en) * 2020-12-12 2024-10-24 Iocure, Inc. Iodine delivery compounds
WO2024201560A1 (en) * 2023-03-24 2024-10-03 Me.Link Co., Ltd. Iodine containing colloidal liquid composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ксензенко В.И. и др. Химия и технология брома, иода и их соединений. - М.: Химия, 1979, с.213-221, 268. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая

Also Published As

Publication number Publication date
JP2003510243A (ja) 2003-03-18
NO20001673L (no) 2000-05-24
JP4187410B2 (ja) 2008-11-26
EP1024815B1 (en) 2003-01-29
KR20010030861A (ko) 2001-04-16
KR100412219B1 (ko) 2003-12-24
CA2301503A1 (en) 1999-05-06
CN1150904C (zh) 2004-05-26
AU1122799A (en) 1999-05-17
DK1024815T3 (da) 2003-05-19
PT1024815E (pt) 2003-06-30
US5885592A (en) 1999-03-23
BR9812588A (pt) 2000-07-25
IL134778A0 (en) 2001-04-30
DE69811105T2 (de) 2003-11-06
ATE231725T1 (de) 2003-02-15
ES2191973T3 (es) 2003-09-16
NO20001673D0 (no) 2000-03-31
CA2301503C (en) 2005-01-04
DE69811105D1 (de) 2003-03-06
WO1999021567A1 (en) 1999-05-06
CN1272789A (zh) 2000-11-08
AU750627B2 (en) 2002-07-25
EP1024815A1 (en) 2000-08-09

Similar Documents

Publication Publication Date Title
JP4187410B2 (ja) 分子ヨウ素経口投与のための方法および医薬組成物
DE3020724C2 (de) Verfahren zur Herstellung pharmazeutischer Zusammensetzungen mit Retardwirkung
US4357469A (en) Carrier base material for prolonged release therapeutic compositions
SU1544173A3 (ru) Способ получени сукральфата
US7381428B2 (en) Stabilized lanthanum carbonate compositions
JP2525478B2 (ja) 安定性の改良された活性型ビタミンd▲下3▼類固型製剤
FI77371B (fi) Foerfarande foer framstaellning av en kapsel, som innehaoller ett alkaliskt aemne och acetylsalicylsyra.
JP2907299B2 (ja) 胃酸を結合する薬学的製剤
US8263119B2 (en) Capsule formulations containing lanthanum compounds
JPS6191137A (ja) 外用薬剤組成物
KR20040031780A (ko) No를 사용한 손톱 감염의 치료 방법
ES2766377T3 (es) Composición para la profilaxis de la candidiasis
CA3009332A1 (en) Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereof
AU3371300A (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
JPS61275220A (ja) 新規薬学的組成物
JPS63284126A (ja) 糖尿病治療剤
Verzijl et al. In vitro cyanide release of four Prussian blue salts used for the treatment of cesium contaminated persons
Sarma et al. An experimental investigation based on a novel gastro-retentive raft liquid dosage form in tandem with controlled-release strategies for oral delivery of metronidazole
MXPA00003219A (en) Pharmaceutical compositions for oral administration of molecular iodine
US20030026852A1 (en) Molecular iodine pharmaceutical composition
WO2003103689A1 (en) Molecular iodine pharmaceutical composition
US20140193525A1 (en) Methods for treating or preventing radiocontrast agent induced kidney injury
JPH0566930B2 (cg-RX-API-DMAC7.html)
Slikkerveer et al. Bismuth: Biokinetics and neurotoxicity
Bettis The effect of complexation upon the physiological availability of Theophylline

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20091028